373 related articles for article (PubMed ID: 32950605)
1. Transcriptomics and solid tumors: The next frontier in precision cancer medicine.
Tsimberidou AM; Fountzilas E; Bleris L; Kurzrock R
Semin Cancer Biol; 2022 Sep; 84():50-59. PubMed ID: 32950605
[TBL] [Abstract][Full Text] [Related]
2. The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology.
Lin VTG; Yang ES
J Natl Cancer Inst; 2019 Oct; 111(10):1016-1022. PubMed ID: 31165154
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
4. Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine.
Supplitt S; Karpinski P; Sasiadek M; Laczmanska I
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572595
[TBL] [Abstract][Full Text] [Related]
5. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
6. A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
Van Allen EM; Robinson D; Morrissey C; Pritchard C; Imamovic A; Carter S; Rosenberg M; McKenna A; Wu YM; Cao X; Chinnaiyan A; Garraway L; Nelson PS
Oncotarget; 2016 Aug; 7(33):52888-52899. PubMed ID: 27167109
[TBL] [Abstract][Full Text] [Related]
7. Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology.
Jobanputra V; Wrzeszczynski KO; Buttner R; Caldas C; Cuppen E; Grimmond S; Haferlach T; Mullighan C; Schuh A; Elemento O
Semin Cancer Biol; 2022 Sep; 84():23-31. PubMed ID: 34256129
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization.
Sager M; Yeat NC; Pajaro-Van der Stadt S; Lin C; Ren Q; Lin J
Expert Rev Mol Diagn; 2015; 15(12):1589-603. PubMed ID: 26565429
[TBL] [Abstract][Full Text] [Related]
9. Spatial transcriptomics in cancer research and potential clinical impact: a narrative review.
Cilento MA; Sweeney CJ; Butler LM
J Cancer Res Clin Oncol; 2024 Jun; 150(6):296. PubMed ID: 38850363
[TBL] [Abstract][Full Text] [Related]
10. Pediatric oncology enters an era of precision medicine.
Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW
Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740
[TBL] [Abstract][Full Text] [Related]
11. The value of new high-throughput technologies for diagnosis and prognosis in solid tumors.
Pinto R; De Summa S; Petriella D; Tudoran O; Danza K; Tommasi S
Cancer Biomark; 2014; 14(2-3):103-17. PubMed ID: 24878811
[TBL] [Abstract][Full Text] [Related]
12. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
Syn NL; Yong WP; Goh BC; Lee SC
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
[TBL] [Abstract][Full Text] [Related]
13. Managing the genomic revolution in cancer diagnostics.
Nguyen D; Gocke CD
Virchows Arch; 2017 Aug; 471(2):175-194. PubMed ID: 28639053
[TBL] [Abstract][Full Text] [Related]
14. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
Mack SC; Northcott PA
J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
[TBL] [Abstract][Full Text] [Related]
15. Knowledge base toward understanding actionable alterations and realizing precision oncology.
Takeuchi S; Okuda S
Int J Clin Oncol; 2019 Feb; 24(2):123-130. PubMed ID: 30542800
[TBL] [Abstract][Full Text] [Related]
16. Synthetic lethality-mediated precision oncology via the tumor transcriptome.
Lee JS; Nair NU; Dinstag G; Chapman L; Chung Y; Wang K; Sinha S; Cha H; Kim D; Schperberg AV; Srinivasan A; Lazar V; Rubin E; Hwang S; Berger R; Beker T; Ronai Z; Hannenhalli S; Gilbert MR; Kurzrock R; Lee SH; Aldape K; Ruppin E
Cell; 2021 Apr; 184(9):2487-2502.e13. PubMed ID: 33857424
[TBL] [Abstract][Full Text] [Related]
17. RNA sequencing: new technologies and applications in cancer research.
Hong M; Tao S; Zhang L; Diao LT; Huang X; Huang S; Xie SJ; Xiao ZD; Zhang H
J Hematol Oncol; 2020 Dec; 13(1):166. PubMed ID: 33276803
[TBL] [Abstract][Full Text] [Related]
18. At the dawn of the transcriptomic medicine.
Koks G; Pfaff AL; Bubb VJ; Quinn JP; Koks S
Exp Biol Med (Maywood); 2021 Feb; 246(3):286-292. PubMed ID: 32915637
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive genomic profiling for oncological advancements by precision medicine.
Pankiw M; Brezden-Masley C; Charames GS
Med Oncol; 2023 Nov; 41(1):1. PubMed ID: 37993657
[TBL] [Abstract][Full Text] [Related]
20. High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond.
Edsjö A; Russnes HG; Lehtiö J; Tamborero D; Hovig E; Stenzinger A; Rosenquist R;
J Intern Med; 2024 Jun; 295(6):785-803. PubMed ID: 38698538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]